IP Library Granted Patent US 9,447,384
Granted Patent B2
US 9,447,384 · App. 14/352,437 · Granted Sep 20, 2016

Modified arsenite oxidase and a biosensor for detecting arsenite

Inventors: Anthony Edward George Cass (London, GB); Joanne Santini (London, GB); Christopher James Johnson (London, GB)
Assignee: The Bio Nano Centre Limited
C12N9/0004C12Q1/005C12Q1/26C12Y120/09001C12Y120/99001G01N27/447
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,447,384
App. No.
14/352,437
Granted
Sep 20, 2016
Kind
B2
Abstract

The present invention provides an arsenite oxidase enzyme modified to prevent translocation by modification of a translocation signal sequence. A microorganism modified to express the heterologous arsenite oxidase enzyme is also provided by the invention, together with a device for detecting the presence of arsenite in a sample.

Claims (6)

1. A device for detecting the presence of arsenite in a sample, comprising at least one electrode, a redox mediator, and an arsenite oxidase enzyme modified to prevent translocation to the periplasm, wherein the enzyme comprises [1] the native AioA subunit from NT-26, or a variant, homologue or derivative thereof having at least 90% sequence homology to the amino acid sequence of SEQ ID NO:4, and [2] the native AioB subunit from NT-26, or a variant, homologue or derivative thereof having at least 90% sequence homology to the amino acid sequence of SEQ ID NO:3, wherein a portion of the native AioB subunit corresponding to the translocation signal sequence, or a functional fragment thereof, is modified, and wherein said enzyme has arsenite oxidase activity.

2. The device according to claim 1 , wherein the electrode is made of one or more conducting materials, selected from carbon, carbon nanotubes, graphene, graphite, gold, palladium, glassy carbon, nanostructured metal oxides or nanostructured metal.

3. The device according to claim 1 , wherein the redox mediator is selected from metal complexes where the metal exists in two or more different redox states, comprising iron, ruthenium or osmium complexes, and organic molecules that can exist in two or more accessible redox states, comprising cytochromes, conducting organic polymers, conducting organic salts, 2, 6-dichlorophenolindophenol, ferrocene or ferrocene derivatives including ferrocene carboxylic acid and hydroxmethyl ferrocene (ferrocene methanol), Tris (2, 2′-bipyridine) dichlororuthenium (11), tetrathiafulvalene (TTF) and quinones.

4. The device according to claim 1 , further comprising a reference electrode.

5. The device according to claim 4 , wherein the reference electrode comprises a Ag/AgC1 reference redox couple.

6. The device according to claim 1 , wherein the device is a test strip with a micro-structured surface.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2015
From: CASS, ANTHONY EDWARD GEORGE; SANTINI, JOANNE; JOHNSON, CHRISTOPHER JAMES
To: THE BIO NANO CENTRE LIMITED
Reel/Frame 034679/0781 →
Priority Claims (1)
GB 1118026.2 · Oct 19, 2011 · national
Continuity (1)
Related Publication 20140238857A1 · Aug 28, 2014